A single centre, observational, longitudinal study of the responses to human pneumococcal protein vaccine candidates in children undergoing routine adenotonsillectomy

Trial Profile

A single centre, observational, longitudinal study of the responses to human pneumococcal protein vaccine candidates in children undergoing routine adenotonsillectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Bacterial infections; Pneumococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jun 2013 Accrual to date is 100% according to United Kingdom Clinical Research Network.
    • 06 Jun 2013 Accrual to date is 96% according to United Kingdom Clinical Research Network.
    • 19 May 2013 Planned number of patients changed from 45 to 60 United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top